» Articles » PMID: 23951345

Identification of New Dystroglycan Complexes in Skeletal Muscle

Overview
Journal PLoS One
Date 2013 Aug 17
PMID 23951345
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The dystroglycan complex contains the transmembrane protein β-dystroglycan and its interacting extracellular mucin-like protein α-dystroglycan. In skeletal muscle fibers, the dystroglycan complex plays an important structural role by linking the cytoskeletal protein dystrophin to laminin in the extracellular matrix. Mutations that affect any of the proteins involved in this structural axis lead to myofiber degeneration and are associated with muscular dystrophies and congenital myopathies. Because loss of dystrophin in Duchenne muscular dystrophy (DMD) leads to an almost complete loss of dystroglycan complexes at the myofiber membrane, it is generally assumed that the vast majority of dystroglycan complexes within skeletal muscle fibers interact with dystrophin. The residual dystroglycan present in dystrophin-deficient muscle is thought to be preserved by utrophin, a structural homolog of dystrophin that is up-regulated in dystrophic muscles. However, we found that dystroglycan complexes are still present at the myofiber membrane in the absence of both dystrophin and utrophin. Our data show that only a minority of dystroglycan complexes associate with dystrophin in wild type muscle. Furthermore, we provide evidence for at least three separate pools of dystroglycan complexes within myofibers that differ in composition and are differentially affected by loss of dystrophin. Our findings indicate a more complex role of dystroglycan in muscle than currently recognized and may help explain differences in disease pathology and severity among myopathies linked to mutations in DAPC members.

Citing Articles

Validation of a novel western blot assay to monitor patterns and levels of alpha dystroglycan in skeletal muscle of patients with limb girdle muscular dystrophies.

Rajasingham T, Rodriguez H, Betz A, Sproule D, Sinha U J Muscle Res Cell Motil. 2024; 45(3):123-138.

PMID: 38635147 PMC: 11316722. DOI: 10.1007/s10974-024-09670-y.


Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review.

Szwec S, Kaplucha Z, Chamberlain J, Konieczny P BioDrugs. 2023; 38(1):95-119.

PMID: 37917377 PMC: 10789850. DOI: 10.1007/s40259-023-00632-3.


Elucidation of bioinformatic-guided high-prospect drug repositioning candidates for DMD via Swanson linking of target-focused latent knowledge from text-mined categorical metadata.

Ulm J, Barthelemy F, Nelson S Front Cell Dev Biol. 2023; 11:1226707.

PMID: 37664462 PMC: 10469615. DOI: 10.3389/fcell.2023.1226707.


Chemical crosslinking analysis of β-dystroglycan in dystrophin-deficient skeletal muscle.

Murphy S, Zweyer M, Mundegar R, Swandulla D, Ohlendieck K HRB Open Res. 2022; 1:17.

PMID: 35528858 PMC: 9039762. DOI: 10.12688/hrbopenres.12846.2.


Evaluation of the dystrophin carboxy-terminal domain for micro-dystrophin gene therapy in cardiac and skeletal muscles in the DMD rat model.

Bourdon A, Francois V, Zhang L, Lafoux A, Fraysse B, Toumaniantz G Gene Ther. 2022; 29(9):520-535.

PMID: 35105949 DOI: 10.1038/s41434-022-00317-6.


References
1.
Bewick G, Nicholson L, Young C, ODonnell E, Slater C . Different distributions of dystrophin and related proteins at nerve-muscle junctions. Neuroreport. 1992; 3(10):857-60. DOI: 10.1097/00001756-199210000-00009. View

2.
Shim J, Kim T . Relationship between utrophin and regenerating muscle fibers in duchenne muscular dystrophy. Yonsei Med J. 2003; 44(1):15-23. DOI: 10.3349/ymj.2003.44.1.15. View

3.
Bonilla E, Samitt C, Miranda A, Hays A, Salviati G, DiMauro S . Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell. 1988; 54(4):447-52. DOI: 10.1016/0092-8674(88)90065-7. View

4.
Ibraghimov-Beskrovnaya O, Ervasti J, Leveille C, Slaughter C, Sernett S, Campbell K . Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 1992; 355(6362):696-702. DOI: 10.1038/355696a0. View

5.
Rezniczek G, Konieczny P, Nikolic B, Reipert S, Schneller D, Abrahamsberg C . Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. J Cell Biol. 2007; 176(7):965-77. PMC: 2064082. DOI: 10.1083/jcb.200604179. View